Pennsylvania House Bill 353, under 2018 Act 96, goes into effect on October 24, 2019 requiring all controlled substances to be electronically prescribed and received by the filling pharmacy. This includes all Schedule II through V drugs. The law replaces all prior methods of prescribing controlled substances to a patient, including paper scripts.
If you are a physician or practice manager impacted by this legislation, we invite you to learn about Quanum ePrescribing from Quest Diagnostics. This service includes Electronic Prescribing for Controlled Substances (EPCS), and can be acquired as part of Quanum EHR, or purchased standalone for a low monthly fee. In alignment with the legislative goals outlined in the act, our DEA-certified EPCS offering has the potential to reduce medication errors, prescription theft, and forgery.
If your practice is unable to comply with the state’s mandate requirements by October 24, 2019 and does not meet any of the exceptions specified in Act 96, you may petition the Pennsylvania Department of Health for an exemption based upon economic hardship, technical limitations, or exceptional circumstances. For additional details, click here to view the Temporary Exemption Form.
The EPCS mandate deadline for Pennsylvania is quickly approaching. To learn how Quest Diagnostics can help you comply with the upcoming changes, please view our complete brochure, EPCS in Pennsylvania, or contact Sales Support at 1.888.835.3409 or via email.
Are you practicing in another state and interested in ePrescription mandates that may apply to you? If so, check out our recent blog post, “EPCS mandates: Are you prepared?”, to get up to speed on the status of EPCS requirements in your state.